Thermo Fisher Scientific Bioproduction Articles

51. Achieving High Cell Purity In Cell Therapy Manufacturing 5/31/2023

    Explore one companies experience with a magnetic separation system used at a vital step in cell therapy development to improve their cell purity.

52. Accelerating The Arrival Of Immuno-Oncology 2.0 5/30/2023

    A new era of optimized cell therapy manufacturing is on the horizon, however, development and collaboration are needed in three key areas to overcome the challenges immuno-oncology 2.0 faces.

53. Reduce Supply Chain Disruptions With Second Sourcing 3/16/2023

    Follow one CDMO's collaboration with Thermo Fisher Scientific to combat supply chain risks after one of the high-volume raw materials critical to their manufacturing process experienced a global shortage.

54. Tailoring The Expansion Process And Process For Longer Workflows 10/17/2022

    This article addresses the focus on the variability and importance of having robust young (T_CM) populations for efficacious therapies.

55. Improving Workflow Automation And Process Control 10/17/2022

    Learn about optimizing your T cell manufacturing process and reducing operating costs with rocking bioreactors using CTS OpTmizer T Cell Expansion SFM.

56. Impact Of Media, Stirred-Tank Bioreactors On Cell Therapy Manufacturing 10/14/2022

    Rocking motion bioreactors have long been the mainstay in T-cell therapy, but stirred-tank bioreactors have garnered a lot of excitement because of several potential advantages.

57. Deliver Product Quality, Enhance Productivity In CHO-K1, CHO-S Cells 6/20/2022

    Early identification of a robust, commercially available, optimized platform medium and cell line–specific feed could be the keys to achieving strong productivity and delivering product to market more rapidly.

58. Improve Productivity In CHO-K1, CHO-S, And DG44 Cells 4/18/2022

    This commercially available platform can enhance process productivity and reduce development time, thereby enabling potential reductions in manufacturing costs and accelerating time-to-market.

59. Single-Use Solutions For Research And Process Development 4/12/2022

    Can supply chain assurance be maintained while offering an array of possibilities to achieve complex process designs? Learn if you could benefit from a modularized, standardized single-use manifold design.

60. Reducing Risk During CAR T Cell Therapy Development And Manufacture 1/26/2022

    It is essential to identify potential areas for optimization early in CAR T cell therapy development—particularly with respect to equipment, reagents, and analytics.